Skip to content

Dysfunctional Attention Processes in Fear of Blushing: Specificity and Changeability

Clinical Specificity of Dysfunctional Habitual Attention Processes in Fear of Blushing and Their Changeability

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00751465
Enrollment
82
Registered
2008-09-12
Start date
2008-11-30
Completion date
2010-12-31
Last updated
2015-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Phobia, Social

Keywords

Social Anxiety Disorder, Social Phobia, Fear of blushing, attention, attention training, cognitive behavior therapy

Brief summary

Blushing is associated with a heightened self-focused attention. In our study we are interested if this self-focused attention can be shown experimentally and if it can be changed by therapy and training. For the experimental part of the study, we want to compare blushing fearful individuals to social anxious participants who are not fearful of blushing and to healthy controls who report to blush either seldom or quite often. In the therapeutical part of our study, we compare an attention training to the standard cognitive behavioral therapy for social anxiety disorder in an intensive group therapy approach.

Detailed description

Fear of blushing is a specific syndrome in social anxiety disorder. Although attentional biases for social anxiety disorders have often been reported, specific data for fear of blushing are still missing. In this study, dysfunctional attention processes are examined by the use of various questionnaire measures and attention tests (e.g. Stroop test, task switching paradigm) comparing fear of blushers, other social phobia patients, healthy volunteers who report to blush seldomly respectively often. The second goal of the study is to examine if these attention processes can be changed by training and therapy. Therefore, individuals who fulfill DSM-IV criteria for social anxiety disorder and report fear of blushing as main problem, are treated with attention training and with CBT for social anxiety disorder. Therapy will be held in the form of intensive weekend group therapy. Differences in outcomes for both therapy types and in changeability of attention processes on objective test data are examined. Stability of results are tested up to 6-month and 12-month after post-assessment.

Interventions

BEHAVIORALTask Concentration Training

Task Concentration Training TCT following Bögels et al. (1997).

BEHAVIORALStandard CBT

Standard CBT following the Clark-and-Wells (1995) model of social anxiety disorder, relying on the German manual for SAD (stangier et al., 2006). Includes the model, role-plays with and without safetey behavior, video-feedback.

Sponsors

German Research Foundation
CollaboratorOTHER
Technische Universität Dresden
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* Social anxiety disorder (DSM-IV criteria) and fear of blushing as main complaint * age: 18-70

Exclusion criteria

* acute severe depression or bipolar disorder * any disorder of ICD group F2 * acute and severe substance misuse * any bodily illness which hinders from study participation

Design outcomes

Primary

MeasureTime frameDescription
Brief Social Phobia Scalepre, within, post, 6-months, and 12-months follow-upBrief Social Phobia Scale BSPS is an interview assessing fear and avoidance in seven social situations and severity of four bodily symptoms.

Secondary

MeasureTime frameDescription
Social Phobia Compositepre, within, post, 6-months, and 12-months follow-upThe social phobia composite includes several self-report measures like the Liebowitz Social Anxiety Scale, Social Phobia Scale, Social Interaction Anxiety Scale, and Social Phobia Inventory.
Changes in objective attention test datawithin, post, 6-months follow-up

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026